Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Browse the detailed record of transactions filed by Nolan Mangini Siobhan. Insider active across 2 companies, notably NGM Biopharmaceuticals INC. Cumulatively, 5 filings have been recorded. Activity tracked since 2 March 2023. The latest transaction was disclosed on 2 July 2026 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations
Nolan Mangini Siobhan is a declarant linked to Alight, Inc. / Delaware, where he is Director, and to NGM Biopharmaceuticals INC, where he is President and CFO. The record shows 4 filings in total, and the 4 sampled recent filings cover the period from 2023-03-06 to 2026-07-07, with buy and sell amounts of EUR 0 across those recent filings; the most common transaction nature is Attribution.